1/415
Looks like no tags are added yet.
Prostaglandin E2
- produced by gastric mucosa,
- inhibits acid secretion and stimulates mucus and bicarbonate secretion = cytoprotective
- NSAIDs decrease the production
Cholinergic
Dicylcomine blocks ______________________ receptors
H2-Histamine
Cimetidine blocks the ____________________ receptor
Prostaglandin
Misoprostol stimulates the ___________________ receptor
-Proton pump inhibitors
-Histatmine H2-receptor antagonists
-Antacids
-Anti-refluxants
main categories of acid suppressants
• Weight loss
• Elevation of the head end of the bed and avoidance of food 2-3 hrs before bedtime
-Avoid foods that can cause irritation of mucosa
• Avoid alcohol consumption and no smoking.
lifestyle modifications for GERD
• LNf (Laparoscopic Nissen fundoplication)
• Bariatric surgery (in obese patients)
anti-reflux surgeries
OTC antacids, H2-receptor antagonists or [PPIs for 2 weeks QD]
how do pts typically self treat for mild GERD
increasing
Pharmacologic treatment for GERD typically involve ___________________ the pH of gastric contents
Alarm symptoms
Recurring symptoms after 2 weeks of lifestyle modification/self treatment
Prescription strength H2RAs or (PPIs for 8 weeks QD) + maintenance therapy if symptoms recur
when are prescriptions for GERD indicated?
Proton pump inhibitors (PPI's)
provide the greatest symptom relief and the highest healing rates for GERD, especially for patients with erosive disease or moderate-to-severe symptoms or with complications.
8-12 weeks of twice-daily PPI therapy
treatment for Patients with erosive esophagitis on endoscopy
Proton pump inhibitors (PPI's)
the drug of choice for maintenance of patients with moderate-to-severe GERD
Antacids
acid neutralizers
-Histamine H2-Receptor Antagonists
-Proton pump inhibitors (PPI's)
acid reducers
aka antisecretory agents
-Calcium carbonate
-Magnesium
-Magnesium-Aluminum-Simethicone
-Sodium Bicarbonate
-Antacid + Alginic Acid
Antacids
Antacids
• Mechanism: neutralize gastric acid → ↑ gastric pH
• Fast acting (w/in minutes) & short duration (30-60 min)
• Most suitable for mild, infrequent symptoms
• Unpleasant taste
• Electrolyte disturbances
adverse effects for antacids
constipation or loss stools
AEs for antacid: calcium carbonate
Constipation
AEs for antacid: aluminum
Loss stools, Diarrhea
AEs for antacid: magnesium
-Gastric distension
-belching
-metabolis alkalosis
AEs for antacid: sodium bicarbonate and calcium carbonate
Antacids
GERD medication that is a safer choice for pregnancy
• Tetracyclines
• Fluoroquinolones
• Itraconazole
• Iron
Antacids should not be taken within 2 hours of ______________________________________
• Famotidine
• Ranitidine
• Nizatidine
• Cimetidine
Histamine-2 receptor antagonists (H2RAs)
Histamine-2 receptor antagonists (H2RAs)
Indications:
• GERD
• PUD
• Dyspepsia/indigestion (non-ulcer)
• Stress ulcer prophylaxis
• Critically ill patients (ICU)
Histamine-2 receptor antagonists (H2RAs)
-reversibly inhibit H2 receptors on gastric parietal cells
-decrease gastric acid secretion
-increase gastric acid pH
-highly selective and last 4-10 hours
• IV admin in critically ill
Cimetidine
may cause gynecomastia or impotence in men & galactorrhea in women with long-term use
Can cause Vitamin B12 deficiency
Histamine-2 receptor antagonists (H2RAs)
• Diarrhea or constipation
• Headache
• Fatigue
• Myalgias
-increased risk for pneumonia
-mental status changes
Histamine-2 receptor antagonists (H2RAs)
• ↓ absorption of drugs requiring low stomach pH for dissolution
• May have additive effects with CNS depressants
• May inhibit gastric first-pass metabolism of ethanol
• Antacids reduces the absorption
Proton pump inhibitors (PPI's)
-irreversibly binds and inactivates active H+/K+ ATPase pumps in parietal cells
-blocks acid secretion
Proton pump inhibitors (PPI's)
-take on an empty stomach 1 hour before meal
-duration is 24 hours
-all are prodrugs
-It takes 3-4 days of daily dosing for full acid-inhibition.
• >90% duodenal ulcers healed w/in 4 wks
• >90% gastric ulcers healed w/in 8 wks
• *Omeprazole
• *Esomeprazole
• *Lansoprazole
• Dexlansoprazole
• Rabeprazole
• Pantoprazole
Proton pump inhibitors (PPI's)
Proton pump inhibitors (PPI's)
Indications:
• GERD
• PUD
• A drug of choice for maintenance therapy in GERD
• Non-ulcer dyspepsia (benefit 10-20% of pts. above placebo)
• Erosive esophagitis
• Esophageal stricture
• Gastric hypersecretions (e.g., gastrinoma)
• Stress ulcer prophylaxis (critically ill patients)
Proton pump inhibitors (PPI's)
AEs:
-C. diff infection
-pneumonia
-fractures of hip, wrist, and spine
-gastric acid rebound or reflux symptoms
-iron deficiency anemia
• Calcium citrate
• B12 via intranasal or IM route
• Iron via IV route
if needed, what supplementation can you give with Proton pump inhibitors (PPI's)
• Helicobacter pylori
• Chronic NSAIDs (including aspirin)
• Acid hypersecretion
common causes of PUD
Bismuth Quadruple Therapy:
-Bismuth + metronidazole + tetracycline + PPI
Concomitant Quadruple Therapy:
-Clarithromycin + amoxicillin + metronidazole + PPI
Triple Therapy:
-Clarithromycin + Metronidazole + PPI
or
-Clarithromycin + amoxicillin + PPI
Preferred treatment regimen for H. pylori induced ulcer
• Discontinue NSAID, (may give sucralfate)
• Initiate H2RA or PPI
treatment for NSAID-associated ulcers
PPI to promote ulcer healing
treatment for NSAID-associated ulcers if NSAID cannot be discontinued
-Metronidazole
-Tetracycline
-Clarithromycin
-Amoxicillin
Abx used to erradicate H. pylori in PUD
Metronidazole
-Metabolized by bacteria into reduced reactive compounds
-damages bacterial DNA, proteins, and membranes to cause cell death
-anaerobic bacteria, protozoans, and H. pylori
Metronidazole
CIs:
-alcohol use within 3 days
-Use within 2 weeks of disulfiram
AEs:
-GI upset
-headache
Tetracycline
-Binds 30s ribosomal subunit
-inhibits attachment of aminoacyl-tRNA
-decreases protein synthesis
-for G+ and G- bacteria, some anaerobes, Rickettsia, Chlamydia, Mycoplasma
-H. pylori
Tetracycline
CIs:
-last half of pregnancy
-children
Clarithromycin
-binds 50s ribosomal subunit
-decreases peptide bond formation
-decreases protein synthesis
-G+ bacteria (not enterococci), intracellulars, atypicals, and H. pylori
Clarithromycin
AEs:
-motility (GI issues)
-Arrhythmias
-Cholestatic hepatitis
-rash
-eosinophilia
Amoxicillin
-Bind PBPs
-decreases peptidoglycan crosslinking
-decreases bacterial cell wall synthesis
-G+ bacteria, enhanced G- bacteria coverage, H. pylori
-often used with beta-lactamase inhibitor
Amoxicillin
AEs:
-rash
-GI upset (diarrhea)
-serious allergic rxn (Contraindication)
• May ↓ effectiveness of hormonal contraception.
-Sucralfate
-Misoprostol
-Bismuth Compounds
gastric mucosa protectants
Sucralfate
-forms viscous protective paste that binds selective ulcers and erosions
-may stimulate mucosal prostaglandin and bicarbonate secretion
-primarily excreted in feces
-administer on an empty stomach
Sucralfate
• Indication: Ulcer (duodenal, gastric, stress prophylaxis)
• Clinical use limited by H2RAs and PPIs
-AE: constipation
Misoprostol
-prodrug
-prostaglandin (PGE1) analog
-acid inhibitory and mucosal protective properties
• Admin' TID or QID
Misoprostol
Indications:
• Duodenal ulcer
• Prophylaxis of NSAID-induced ulcer (PPIs preferred)
• Adverse effects: GI upset (pain, nausea, diarrhea)
• Contraindications: pregnancy, childbearing potential
Bismuth compounds
• Coats ulcers & erosions, protects against acid & pepsin
• Direct antimicrobial (H. pylori) effects; binds enterotoxins
• May stimulate prostaglandin, mucus, and bicarbonate secretion
Bismuth compounds
Indications
• Dyspepsia, indigestion
• Acute diarrhea, upset stomach
• H pylori GI infection
Bismuth Subsalicylate
Contraindications
• Salicylate allergy
• Child/teenager recovering from viral infection (e.g., chicken pox, flu) — risk of Reye's Syndrome
• Nursing
• Pregnancy >20 weeks
Adverse effects
• Dark tongue or stool (harmless) (bismuth)
• Salicylate toxicity (high dose/prolonged use)
-Bethanechol
-Metoclopramide
promotility agents
Bethanechol
• Stimulates M3 receptors on muscle cells and at myenteric plexus synapses
• Increases LES pressure in GERD
Bethanechol
Indication
• Urinary retention
• No longer used for GERD due to adverse effects + better agents available
AEs: GI upset, decreased BP with reflex tachycardia, urinary urgency
Metoclopramide
-Blocks dopamine (D2) receptors
-prevents inhibition of cholinergic smooth muscle stimulation
-increases esophageal peristaltic amplitude
-increases LES pressure and gastry emptying
-potential antinausea and antiemetic action in chemoreceptor trigger zone of medulla
Metoclopramide
Indications
• GERD (not effective in erosive esophagitis)
• Diabetic gastroparesis
• Nausea/vomiting (chemotherapy-induced, postoperative)
Metoclopramide
Adverse effects
• Drowsiness, insomnia, anxiety, agitation
• Dystonia, akathisia, parkinsonism
• Elevated prolactin levels → galactorrhea, gynecomastia, impotence, menstrual disorders
• Tardive dyskinesia (avoid long term use, if possible!)
Contraindications
• Epilepsy (↑ risk of seizures)
• GI hemorrhage, mechanical obstruction, or perforation
• Pheochromocytoma (↑ risk of hypertensive crisis)
• Sulfasalazine
• Olsalazine
• Balsalazide
• Mesalamine
5-Aminosalicylates (5-ASA)
•5-Aminosalicylates (5-ASA)
•Corticosteroids
•Immunosuppressives
• Janus kinase inhibitors
• S1P receptor modulator
• Biologics
Drug categories used to treat IBD
-Infliximab
-Adalimumab
-Golimumab
-Certolizumab
Anti-TNF biologics
-Vedolizumab
-Natalizumab
Anti-integrins (CAM inhibitors)
Ustekinumab
Interleukin (IL)-12/23 antagonist
Risankizumab
Interleukin-23 (IL-23) inhibitor
Tofacitinib
Janus kinase inhibitors
Ozanimod
S1P receptor modulator
Azathioprine and mercaptopurine
Thiopurines (immunosuppresive)
Mesalamine
formulated 5-aminosalicylic acid (5-ASA)
5-Aminosalicylates (5-ASA)
• Thought to work topically
-Activates the production of IL-1, TNF-alpha, and PPARy
-Inhibits lipoxygenase pathway and NFκ β
Mesalamine
-coated in a pH sensitive coating that dissolves at pH 6-7 to release in small intestine and colon
-suppository form is suspended in a wax matrix
-enema form
- Asacol, Apriso, Lialda, Delzicol, and Pentasa
Which ever formulation is relased at the location that is inflamed in the GI tract
How do you pick with 5-ASA to use?
5- Aminosalicylates (5-ASA)
• 1st line - induce/maintain remission in mild-moderate UC
• Not recommended for CD due to lack of efficacy but still widely used
5- Aminosalicylates (5-ASA)
Contraindications
• Hypersensitivity to salicylates (e.g., aspirin)
• Adolescent recovering from viral infection (↑ Reye's syndrome risk)
• Hypersensitivity to sulfonamides (sulfasalazine only)
AEs:
-headache
-dyspepsia
-skin rash
-rarely nephrotoxicity
Sulfasalazine (5-ASA)
AEs:
-headache, nausea, fatigue
-rash, fever, Stevens-Johnson syndrome , pneumonitis, hemolytic
anemia, myelosuppression
• Inhibits intestinal folate absorption- administer with folate
• Oligospermia (reversible)
Glucocorticoids (GCs)
• Anti-inflammatory & immunosuppressive actions
-decreases production and expression of: TNFα, IL-1, IL-8, inflammatory cell adhesion molecules, Phospholipase A2, Cyclooxygenase, and NF-kB
Glucocorticoids (GCs)
-bind to receptors and release Hsp90
-actiavted GCR binds to GREs on gene that result in expression of proteins that suppress immune response, inflammation
Prednisone
• Most common GC used for induction of remission in CD
• Converted to active moiety after 1st pass metabolism
• Intermediate duration of action → Qday dosing
• Most patients respond within 10-14 days and dose can be tapered
Methylprednisolone
which is preferred?
Methylprednisolone or hydrocortisone
Budesonide
-synthetic corticosteroid
-oral once daily, rectal, enema, and suppository forms
• Greater affinity (15x) for GC receptor
-low systemic bioavailability
-
Glucocorticoids (GCs)
-used to induce remission of IBD but not to maintain remission
-avoid long term use
• PO for moderate-severe active IBD
• Admin IV if severely ill
Budesonide
__________________________ PO controlled release useful in:
• Mild-moderate CD of ileum and proximal colon (Entocort®)
• Mild-moderate UC (Uceris®)
Oral Glucocroticoids (GCs)
Short-term systemic side effects
• insomnia, weight gain, emotional lability, GI upset, ↑ blood pressure and blood glucose
Long-term systemic use side effects
• cataracts, hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing's, immunosuppression, osteoporosis, delayed growth in children, acne
• Azathioprine
• Mercaptopurine
Purine Analogs (immunosuppressives)
Purine Analogs
• Impairs purine biosynthesis and inhibit cellular proliferation of immune cell
• These are prodrugs that are metabolized to their active form:
Purine Analogs
Use -maintain remission (UC, CD)
• Mod-Severe IBD
• Steroid resistant / steroid dependent
• Used as an adjunct to glucocorticoids & biologics
• Treatment with TNFα inhibitors and Aza along with surgery is used for treatment of fistulizing Crohn's
Purine Analogs
• Delayed onset - 17 wks (average)
• ~50% achieve remission in 3-6 months; maintain remission in 80%
-monitor TPMT enzyme activity
-avoid in breast feedin
Purine Analogs
Adverse effects:
• GI upset (severe n/v/d)
• Bone marrow suppression leads to - ↓CBC count
• Hepatotoxicity
-increases risk of lymphoma, hematologic toxicities, and mutagenic potential
DIs:
-allopurinol, febuxostat, mesalamine, ACEis, Trimethoprim/sulfamethoxazole, Warfarin
Folic Acid Analog
(Methotrexate)
-immunosuppressive & anti-inflammatory
-Irreversibly inhibits dihydrofolate reductase
• ↓ thymidine & purine producon = interferes w/ DNA synthesis/repair
• May ↓ IL-1 & ↑ adenosine
• IM weekly
Folic Acid Analog
(Methotrexate)
• Use - Maintenance of CD remission
• off label as alternative to thiopurine to withdraw corticosteroid
• Delayed onset ~ 12 weeks
CIs:
• Pregnancy/breastfeeding
• Alcoholism
• Chronic liver disease
• HIV/AIDS
• Preexisting blood dyscrasias
Folic Acid Analog
(Methotrexate)
Adverse effects
• Bone marrow, liver, lung, skin, and kidney toxicities (monitor)
• Fetal death, congenital anomalies
• Folate (Vit B9) deficiency
• Supplement with folic acid or folinic acid
DIs:
• Live vaccines (↑ risk of infection)
• NSAIDs
TNFα Inhibitors
-immunosuppressive & anti-inflammatory
• Delayed onset - ~2 weeks
Use -induce/maintain remission
• G.I.A for UC
• C.I.A for CD
TNFα Inhibitors
Adverse effects:
• Infusion/injection reactions
• Serious infection
• Reactivation of TB
• Antibodies to the antibody
• Delayed serum-sickness-like reaction
CAM Inhibitors (aka Anti-integrins)
-Monoclonal antibody that binds to and inhibits the α4-integrin subunit.
-they block binding of α4β1 and α4β7 on lymphocytes to MADCAM 1 and prevent lymphocyte recruitment to the intestinal mucosa
Vedolizumab
-binds to α4ß7 integrins found on T-lymphocytes
-use: induction/maintenance of moderate-severe CD or UC
CAM Inhibitors (aka Anti-integrins)
• Admin IV over 30-60 min; DC if no response after 12-14 wks
-can be considered if failure to respond to corticosteroids or are intolerant TNFα inhibitor